학술논문

A phase I study targeting the APE1/Ref-1 DNA repair-redox signaling protein with the APX3330 inhibitor
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; DEC 2019, 18 12, 2p. Supplement: S
Subject
Language
English
ISSN
15388514